ZLD
Zelira Therapeutics Limited
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
6
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Zelira Therapeutics Ltd. is a bio-pharmaceutical company. The company is headquartered in Perth, Western Australia. The company went IPO on 2003-07-28. The firm is engaged in the research, development and commercialization of clinically validated cannabinoid-based medicines. The company owns a portfolio of products and a pipeline of candidates undergoing clinical development positioned to enter global markets. The company is focused on developing and clinically validating branded cannabinoid-based medicines in its prescription [Rx] business for the treatment of a variety of medical conditions, including insomnia, autism and chronic non-cancer pain, as well as offering over the counter [OTC] products. The company has two medications: HOPE and ZENIVOL. ZENIVOL is a cannabinoid-based medicine for the treatment of chronic insomnia. The firm in partnership with SprinJeneCBD, introduced a full line of oral care products, including SprinJeneCBD toothpaste product, which is a hemp-derived, oral care products containing cannabinoids, blackseed oil and zinc utilizing patented technology.
📈 Performance
Price History
-35.54%
1M
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
0%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.94
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in ZLD
6
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in ZLD
866 days
ZLD investor breakdown
💵 Income of investors
More than 200k
150k - 200k
17%
100k - 150k
33%
50k - 100k
33%
Less than 50k
17%
👶 Age of investors
18 - 25
17%
26 - 34
17%
35 - 90
67%
🙋 Legal gender of investors
Female
67%
Male
33%
Pearlers who invest in ZLD also invest in...
Incannex Healthcare Ltd. is a clinical stage pharmaceutical development company, which engages in the research and development associated with medicinal cannabinoid and psychedelic pharmaceutical products and therapies. The company is headquartered in Melbourne, Victoria. The company went IPO on 2007-05-23. The firm is engaged in the research and development associated with medicinal cannabinoid and psychedelic pharmaceutical products and therapies. The firm targets five indications: obstructive sleep apnea (OSA), traumatic brain injury and concussion (TBI), rheumatoid arthritis (RA), inflammatory bowel disease (IBD) and inflammatory lung conditions. Its drug candidates include IHL-42X, IHL-216A, Psilocybin-assisted psychotherapy for general anxiety disorder (Psi-GAD) and IHL-675A. Its IHL-42X is a cannabinoid combination product for treatment of OSA. Its IHL-675A comprises a combination of hydroxychloroquine and CBD for prevention and treatment of inflammatory lung conditions, rheumatoid arthritis and inflammatory bowel diseases. IHL-216A is a cannabinoid combination product for the treatment of TBI. The company is investigating the use of psilocybin-assisted psychotherapy to treat GAD.
📊 Share price
$0.12 AUD
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
📊 Share price
$57.36 AUD
NULL GLOBAL
NULL SMART BETA
Carnegie Clean Energy Ltd. engages in the development and ownership of the patented CETO wave energy technology. The firm is focused on the development and commercialization of its CETO and MoorPower wave energy technologies and complimentary products, including the Wave Predictor and Mooring Tensioner. CETO is a submerged, point absorber type wave energy technology. CETO is an advanced wave energy system suitable for a range of remote and utility scale markets globally. MoorPower is an integrated wave energy system for offshore demand applications such as offshore aquaculture. Wave Predictor is a system capable of precisely predicting upcoming waves using a machine learning algorithm that enables intelligent control for wave energy converters and supports optimized performance and costs. Mooring Tensioner is a product that provides the passive tension required for rotary electric power take-off systems. Its projects include Garden Island Microgrid, Microsoft AI for Earth project, CETO Next Generation and others.
📊 Share price
$0.00 AUD
ETHI.AX was created on 2017-01-05 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to track the performance of an index (before fees and expenses) that includes a portfolio of large global stocks identified as Climate Leaders that have also passed screens to exclude companies with direct or significant exposure to fossil fuels or engaged in activities deemed inconsistent with responsible investment considerations.
📊 Share price
$12.45 AUD
NULL GLOBAL
NULL SMART BETA
NULL ETHICAL
NULL EX AUSTRALIA
ESGI.AX was created on 2018-03-06 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to provide investment returns before fees and other costs which track the performance of its Reference Index in Australian dollars.
📊 Share price
$29.97 AUD
NULL GLOBAL
NULL SMART BETA
NULL ETHICAL
NULL THEMATIC
Want more shares? Try these...
Zinc of Ireland NL engages in the mineral exploration and project evaluation. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2007-09-18. The firm is focused on its zinc/lead projects in the Republic of Ireland, as well as at its Earaheedy zinc/lead/silver exploration project in Western Australia. Its flagship Kildare Project is located approximately 40 kilometers (km) southwest of Dublin. The Kildare Project is situated within the Rathdowney Trend, within 80 km of the zinc mines: Lisheen and Galmoy. The Earaheedy license is located approximately 200 km east of Wiluna and 220 km southeast of the RTR Chinook and Magazine Pb-Zn discoveries. The Earaheedy license contains approximately 23 km of strike of the target unconformity between the Frere and Yelma formations. The Paleoproterozoic Frere Formation is comprised of granular iron-formation, granular siliceous iron-formation, peloidal chert, siltstone and sandstone and unconformably overlies sandstones, siltstones, shales, minor conglomerates and dolomite of the older Yelma Formation.
📊 Share price
$0.02 AUD
ZMM
ZIMI Ltd. is an Australia based company which focuses on Internet on Things smart home technology and services. The Company’s hybrid module provides a quick path to the market for hardware manufacturers to get connected on the Zimi platform. The firm offers its products under three categories: Powermesh, Senoa, and Zimi Connect. Its products under Powermesh include multi-purpose switches, fan and light controllers, double power points, light dimmers, blind controllers, multi-dimmer switches, garage door controllers, and Zimi cloud connect. Its products under Senoa offer multi-dimmer switches, multi-purpose switches, blind controllers, and power point. Its Zimi Smoke Connect connects smoke alarms for a legislated market, which is a smarter smoke alarm with alerts and phone calls. The company also offers Zimi+ Subscription helps the user dashboard platform to manage every usage, connected services and third-party integration. Its lifestyle products include auto-off timers, automatic schedules, energy use, behavior link, voice control, and routines.
📊 Share price
$0.04 AUD
Zip Co. Ltd. provides integrated solutions to small, medium and enterprise merchants across numerous industries, both online and in-store. The company is headquartered in Sydney, New South Wales and currently employs 1,392 full-time employees. The company went IPO on 2009-12-09. The principal activity of the Company is offering point of sale credit and payments to customers and providing integrated retail finance solutions to merchants, both online and in store. Its segments include APAC, Americas, EMEA and Zip Business. APAC segment offers Buy Now Pay Later (BNPL) instalment products or line of credit products to consumers in Australia and New Zealand. Americas segment offers BNPL instalment products to customers in the United States and Canada. EMEA segment offers BNPL instalment products to customers in Europe, the Middle East and South Africa. Zip Business segment provides unsecured loans and lines of credit to small and medium sized businesses in Australia and New Zealand. The company provides fair, flexible and transparent payment options to individual consumers. The company also provides BNPL services to consumers, both online and in store, through the provision of line of credit and instalment products.
📊 Share price
